Pharmacologic therapy of arteriovenous malformations

Eric Van Cutsem, E Van Cutsem, H Piessevaux, Hubert Piessevaux
Gastrointestinal endoscopy clinics of North America · 1996 · vol. 6(4) , pp. 819–832 · doi:10.1016/s1052-5157(18)30345-3 · PMID:8899412 · W2395337418
Review OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-06 ⓘ

Estrogens and progestagens significantly reduce bleeding frequency and intensity in gastrointestinal arteriovenous malformations, while other drugs like danazol, octreotide, desmopressin, and aminocaproic acid have limited supporting evidence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Pharmacologic treatment of bleeding gastrointestinal arteriovenous malformations is difficult. These lesions should be treated pharmacologically only when endoscopic treatment is not successful and bleeding persists or when the lesions cannot be treated endoscopically due to their localization, mainly in the small bowel. These are only a limited number of studies available on the medical treatment of bleeding arteriovenous malformations. There is considerable evidence, however, that a combination of estrogens and progestagens significantly reduces the bleeding frequency and intensity and also the transfusion requirements in patients with high transfusion need. A few other drugs have been tried in patients with bleeding gastrointestinal arteriovenous malformations: danazol, octreotide, desmopressin, and aminocaproic acid. The experience with these drugs, however, is limited to case reports or to small series of patients.

My notes (saved in your browser only)

MeSH descriptors

Arteriovenous Malformations Arteriovenous Malformations Arteriovenous Malformations Clinical Trials as Topic Endoscopy Humans Prognosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (60)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T11:22:51.341741+00:00
pubmed
last seen: 2026-10-08T21:59:55.756364+00:00
unpaywall
last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0 · commercial use OK